首页> 外文OA文献 >Development of a Wilms’ tumor antigen-specific T-cell receptor for clinical trials: engineered patient’s T cells can eliminate autologous leukemia blasts in NOD/SCID mice

【2h】

Development of a Wilms’ tumor antigen-specific T-cell receptor for clinical trials: engineered patient’s T cells can eliminate autologous leukemia blasts in NOD/SCID mice

机译：Wilms的肿瘤抗原特异性T细胞受体的开发用于临床试验：工程患者的T细胞可以消除NOD / SCID小鼠的自体白血病

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Xue, Shao-An; Gao, Liquan; Thomas, Sharyn; Hart, Daniel P.; Xue, John Zhao; Gillmore, Roopinder; Voss, Ralf-Holger; Morris, Emma; Stauss, Hans J.;
展开▼
作者单位

展开▼
年度 2009
总页数
原文格式 PDF
正文语种 en
中图分类

相似文献

外文文献
中文文献
专利

1. Development of a Wilms’ tumor antigen-specific T-cell receptor for clinical trials: engineered patient’s T cells can eliminate autologous leukemia blasts in NOD/SCID mice | Haematologica [J] . Shao-An Xue, Liquan Gao, Sharyn Thomas, Haematologica . 2010,第1期

机译：开发用于临床试验的威尔姆斯肿瘤抗原特异性T细胞受体：工程患者的T细胞可以消除NOD / SCID小鼠的自体白血病母细胞|血液学
2. Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD|[sol]|SCID mice [J] . U Siegler, C P Kalberer, P Nowbakht, Leukemia . 2005,第12期

机译：来自急性髓性白血病患者的活化的自然杀伤细胞对NOD | [sol] | SCID小鼠的自体白血病母细胞具有细胞毒性
3. Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD|[sol]|SCID mice and in NOD|[sol]|SCID mice transgenic for human growth factors [J] . M Feuring-Buske, B Gerhard, J Cashman, Leukemia . 2003,第4期

机译：β2-微球蛋白缺陷型NOD | [sol] | SCID小鼠和人类生长因子转基因的NOD | [sol] | SCID小鼠中人类急性髓系白血病祖细胞的移植改善
4. Development of Highly Potent Formats of Soluble Bispecific T-Cell Receptors for Targeting of Tumor Specific HLA Ligands [C] . Aila Hrle Protein Engineering Summit. . 2018

机译：肿瘤特异性HLA配体靶向溶解性双特异性T细胞受体高效形式的发展
5. Development of a clinical leukemia vaccine using dendritic cells loaded with the Wilms' tumor (WT1) gene product [D] . Van Driessche, Ann. 2011

机译：使用载有威尔姆斯肿瘤（WT1）基因产物的树突状细胞开发临床白血病疫苗
6. Development of a Wilms’ tumor antigen-specific T-cell receptor for clinical trials: engineered patient’s T cells can eliminate autologous leukemia blasts in NOD/SCID mice [O] . Shao-An Xue, Liquan Gao, Sharyn Thomas, 2010

机译：Wilms的肿瘤抗原特异性T细胞受体的开发用于临床试验：工程患者的T细胞可以消除NOD / SCID小鼠的自体白血病
7. Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice [O] . U Siegler, C P Kalberer, P Nowbakht, 2005

机译：来自急性髓细胞白血病患者的激活的天然杀手细胞是NOD / SCID小鼠中对自体白血病爆炸的细胞毒性
8. Analysis of PSA-Specific T-Cell Responses of Prostate Cancer Patients Given a PSA-Based Vaccine on a Clinical Trial [R] . Gulley, J. , Dahut, W. , Arlen, P. M. , 2003

机译：在临床试验中给予基于psa的疫苗的前列腺癌患者的psa特异性T细胞应答分析

Development of a Wilms’ tumor antigen-specific T-cell receptor for clinical trials: engineered patient’s T cells can eliminate autologous leukemia blasts in NOD/SCID mice

著录项

引文网络

相似文献

相关主题

期刊订阅